Evidence map›Paper›PMID 18660811›Full record

ArticleNature immunology2008

The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions.

Damian Kovalovsky, Olisambu U Uche, Sonia Eladad, Robin M Hobbs, Woelsung Yi, Eric Alonzo, Kevin Chua, Maggie Eidson, Hye-Jung Kim, Jin S Im and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 385 papers.

0numbers the graph read from it
0cells of the map it votes in
385citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

385 citing papers in PubMed, 539 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

325 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Damian KovalovskyImmunology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Olisambu U Uche
Sonia Eladad
Robin M Hobbs
Woelsung Yi
Eric Alonzo
Kevin Chua
Maggie Eidson
Hye-Jung Kim
Jin S Im
Pier Paolo Pandolfi
Derek B Sant'Angelo
Memorial Sloan Kettering Cancer Center · USKettering University · USAlbert Einstein College of Medicine · USCornell University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
IMMUNOLOGY RESEARCH TRAININGT32CA009149 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI RUDENSKY, ALEXANDER Y · 1985 to 2022
$4.0M
Immunobiology of NKT cell development and functionR01AI059739 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI SANT'ANGELO, DEREK B. · 2006 to 2010
$2.5M
NCI NIH HHS P30-CA 08748NCI NIH HHS T32 CA009149NIAID NIH HHS AI059739NIAID NIH HHS R01 AI059739
6 · The paper itself

Abstract

Invariant natural killer T cells (iNKT cells) have an innate immunity-like rapidity of response and the ability to modulate the effector functions of other cells. We show here that iNKT cells specifically expressed the BTB-zinc finger transcriptional regulator PLZF. In the absence of PLZF, iNKT cells developed, but they lacked many features of innate T cells. PLZF-deficient iNKT cells accumulated in lymph nodes rather than in the liver, did not express NK markers and did not have the characteristic activated phenotype. PLZF-deficient iNKT cells failed to secrete large amounts of interleukin 4 and interferon-gamma after activation; however, some cells produced either interleukin 4 or interferon-gamma but not both. PLZF, therefore, is an iNKT cell-specific transcription factor that is necessary for full functionality.

Indexed as

Transcription, GeneticAnimalsHumansInterleukin-4Killer Cells, NaturalKruppel-Like Transcription FactorsMicePromyelocytic Leukemia Zinc Finger ProteinTranscription FactorsInterleukin-4Kruppel-Like Transcription FactorsPromyelocytic Leukemia Zinc Finger ProteinTranscription FactorsZBTB16 protein, human

Identifiers

PMID18660811
PMCPMC2662733
OpenAlexW2155255799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.